Important regulatory notice. This page is a research-context summary of the prescription status of GHK-Cu in the United Kingdom. It is not legal or medical advice. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are not for human or veterinary use.
Quick answer. There is no UK prescription pathway for systemic GHK-Cu because there is no MHRA-licensed GHK-Cu medicine for human use. UK prescribers cannot issue an NHS prescription for a medicine that does not exist on the licensed list. Cosmetic GHK-Cu products are sold over the counter by regulated cosmetic retailers and do not require a prescription. Research-use-only GHK-Cu reference compounds are sold to the laboratory market and do not require a prescription, but they are also not for human use.
Why there is no UK prescription pathway
Prescription medicines in the United Kingdom are products that hold a Marketing Authorisation issued by the MHRA. GHK-Cu has no UK Marketing Authorisation for systemic human use. There is therefore no British National Formulary entry, no Summary of Product Characteristics, and no NHS prescription pathway. UK GPs and consultants cannot legally prescribe a substance that does not have a UK marketing authorisation outside very narrow specials and unlicensed-import frameworks, which would not apply here in any standard way.
The cosmetic context
Cosmetic products containing GHK-Cu at low concentration are sold by regulated cosmetic retailers under cosmetics regulation. They are not medicines and do not require a prescription, but they may make only cosmetic claims, not therapeutic claims.
The research-use context
Research-use-only laboratory reference compounds are not medicines, are not for human use, and do not require a prescription because they are not in the medicines framework at all. They are sold to laboratory and academic users.
UK enforcement context
The MHRA in April 2026 opened investigations into UK clinics making therapeutic claims about unregulated peptide products (reported by The Guardian, 4 April 2026). UK clinics that present GHK-Cu as a treatment that ‘does not need a prescription because it is research grade’ are misrepresenting both the regulatory status and the legal protection. The ‘research grade’ label does not exempt a seller from the medicines framework if the product is in fact being marketed for human use.
Frequently Asked Questions
Do I need a prescription for GHK-Cu in the UK?
There is no UK prescription pathway for systemic GHK-Cu because there is no MHRA-licensed GHK-Cu medicine for human use. Cosmetic and research-use-only products are sold without prescription but the latter are not for human use.
Can a private clinic prescribe GHK-Cu?
UK private prescribers are bound by the same MHRA framework as NHS prescribers. There is no UK marketing authorisation for systemic GHK-Cu to support a standard prescription.
Where can I find a registered prescriber?
Your GP or NHS 111 can direct you to appropriate clinical services. The General Medical Council (gmc-uk.org) maintains the register of UK medical practitioners.
Research use only. Peptides Lab UK supplies research-use-only laboratory reference compounds with batch-specific certificates of analysis. Products are not for human or veterinary use.
